Karolinska Development (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:
Stockholm
Average round investment:
8.96M USD

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.

We tracked 11 Nordic investments.

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Karolinska Development investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Karolinska Development mostly invests with:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to Karolinska Development:

InvestorCriteria
Norway Sarsia Seed Management
76%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Sweden Industrifonden
74%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
Sweden SEB Venture Capital
67%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Norway Investinor
65%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 4.2
Sweden Filip Engelbert
64%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 5.7
  • Active last 12 months: Yes
Sweden Jonas Nordlander
61%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 6.2
  • Active last 12 months: Yes
Sweden Bonnier Ventures
60%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 3
Sweden Alfvén & Didrikson
60%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.7
Sweden Eklöf Invest
60%
  • Range for average deal size: 5M - 10M USD
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Finland Tesi (Finnish Industry Investment)
59%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Finland
  • Average number of deals per year: 4.1

News about Karolinska Development

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)